Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC).
Elisa Lodi RizziniAndrea RepaciElena TabacchiLucia ZanoniValentina VicennatiOttavio CavicchiUberto PagottoAlessio Giuseppe MorgantiStefano FantiFabio MonariPublished in: Diagnostics (Basel, Switzerland) (2021)
Our Institutional experience confirmed the role of 18F-FDG PET/CT as a useful guide in the clinical management of RAI-R-DTC and obviated further unnecessary RAIT.